IR@PKUHSC  > 北京大学临床肿瘤学院
学科主题临床医学
Plasma microRNA signatures to predict EGFR-TKI resistance in EGFR-mutant advanced NSCLC patients.
Wang, Shuhang1; Wang, Jie1; Bai, Hua1; An, Tongtong1; Zhao, Jun1; Wang, Zhijie1; Duan, Jianchun1; Zhuo, Minglei1; Wang, Yuyan1; Wu, Meina1
刊名JOURNAL OF CLINICAL ONCOLOGY
2013-05-20
suppl.S期:15
收录类别SCI ; ISTP
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
语种英语
WOS记录号WOS:000335419604661
Citation statistics
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/51483
Collection北京大学临床肿瘤学院
北京大学临床肿瘤学院_胸部肿瘤内科
作者单位1.Beijing Canc Hosp, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China
2.Peking Univ, Canc Hosp, Sch Oncol, Beijing Canc Hosp, Beijing 100871, Peoples R China
3.Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Beijing 100871, Peoples R China
Recommended Citation
GB/T 7714
Wang, Shuhang,Wang, Jie,Bai, Hua,et al. Plasma microRNA signatures to predict EGFR-TKI resistance in EGFR-mutant advanced NSCLC patients.[J]. JOURNAL OF CLINICAL ONCOLOGY,2013,suppl.S(15).
APA Wang, Shuhang.,Wang, Jie.,Bai, Hua.,An, Tongtong.,Zhao, Jun.,...&Wu, Meina.(2013).Plasma microRNA signatures to predict EGFR-TKI resistance in EGFR-mutant advanced NSCLC patients..JOURNAL OF CLINICAL ONCOLOGY,suppl.S(15).
MLA Wang, Shuhang,et al."Plasma microRNA signatures to predict EGFR-TKI resistance in EGFR-mutant advanced NSCLC patients.".JOURNAL OF CLINICAL ONCOLOGY suppl.S.15(2013).
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Wang, Shuhang]'s Articles
[Wang, Jie]'s Articles
[Bai, Hua]'s Articles
百度学术
百度学术Similar articles in
[Wang, Shuhang]'s Articles
[Wang, Jie]'s Articles
[Bai, Hua]'s Articles
必应学术
必应学术Similar articles in
[Wang, Shuhang]'s Articles
[Wang, Jie]'s Articles
[Bai, Hua]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.